Invesco Ltd. Adma Biologics, Inc. Transaction History
Invesco Ltd.
- $557 Billion
- Q2 2025
A detailed history of Invesco Ltd. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 12,818,141 shares of ADMA stock, worth $215 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
12,818,141
Previous 12,866,904
0.38%
Holding current value
$215 Million
Previous $255 Million
8.56%
% of portfolio
0.04%
Previous 0.05%
Shares
23 transactions
Others Institutions Holding ADMA
# of Institutions
407Shares Held
193MCall Options Held
2.13MPut Options Held
1.59M-
Vanguard Group Inc Valley Forge, PA21.4MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
State Street Corp Boston, MA12.1MShares$202 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99.1 Million0.01% of portfolio
-
Nuveen, LLC Charlotte, NC5.56MShares$93.2 Million0.03% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...